If approved, Moderna's mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across ...

The EMA's CHMP has issued a positive opinion recommending the approval of Dupixent in the EU for paediatric patients with CSU ...

BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...

The zenith of this turnaround arrived when Eli Lilly selected Lehigh Valley, an area in eastern Pennsylvania, for a new $3.5bn facility to produce the drugmaker’s forthcoming wave of weight loss ...

Anton Paar introduces the PNR 500, an advanced automatic penetrometer designed for fast, reproducible consistency and penetration testing of semi-solid materials.

Several new guidance documents issued by the FDA are poised to significantly impact the rare disease development landscape.

Boehringer in terms of licensing deals, with a majority of these agreements being oncology or immunology-focused.

Quotient Sciences has extended its commercial partnership with Ipsen, focusing on the production of Sohonos for FOP.

Ahead of Rare Disease Day, Abigail Beaney, editor of Clinical Trials Arena, spoke with Robert Barrie, editor of Pharmaceutical Technology and Frankie Fattorini, reporter for Pharmaceutical Technology ...

Asahi Kasei has signed a definitive agreement to acquire all issued shares of Aicuris Anti-infective Cures for approximately ...

Our viewpoint is that in cases of ultra rare diseases where there is no commercial model or opportunity for traditional forms of investment, access to gene therapies could be provided via a clinical ...

The organised crime group were selling unlicensed weight loss-substances online, using social media to market products.